Qube Research & Technologies Ltd - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 224 filers reported holding SAGE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$3,663,986
+1107.9%
77,924
+879.8%
0.01%
+550.0%
Q4 2022$303,327
-76.2%
7,953
-72.3%
0.00%
-87.5%
Q3 2021$1,272,000
+54.6%
28,697
+98.1%
0.02%
+77.8%
Q2 2021$823,000
-82.8%
14,489
-77.3%
0.01%
-88.2%
Q1 2021$4,783,000
+257.2%
63,907
+313.0%
0.08%
+300.0%
Q4 2020$1,339,000
+74.3%
15,475
-42.1%
0.02%
-40.6%
Q1 2020$768,00026,7380.03%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders